In 2023, the actual sales of antacid medicine in Germany were evaluated at 30 million Euros. The forecast from 2024 to 2028 indicates a steady upward trend, with sales increasing from 30.5 million Euros in 2024 to 32.4 million Euros in 2028. This suggests a consistent year-on-year growth ranging from 1.6% to 1.3% over the forecasted period.

Key insights into future trends include:

Increasing adoption of health-conscious lifestyles may drive further demand for digestive health products, potentially boosting antacid sales.
Regulatory changes and new product innovations could influence market dynamics, encouraging more competition or growth in specific segments.
Economic factors and healthcare policy changes might affect consumer purchasing power and healthcare behaviors, impacting overall market growth.